Ring A structural modified derivatives of withaferin A and the evaluation of their cytotoxic potential

Steroids

Volumn 76, Issue 10-11, 2011, Pages 1213-1222

  Yousuf, Syed Khalid ^a   Majeed, Rabiya ^a   Ahmad, Mudassier ^a   Sangwan, Payare Lal ^a   Purnima, Basant ^a   Saxsena, A K ^a   Suri, K A ^a   Mukherjee, Debaraj ^a   Taneja, Subhash Chandra ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

, Unsaturated group; 3+2 Cycloaddition; Cytotoxicity; Michael addition; Withaferin A

Indexed keywords

2,3 DIHYDROWITHAFERIN A 3 BETA O SULFATE; ADRIYAMYCIN; ANTINEOPLASTIC AGENT; FLUOROURACIL; MITOMYCIN; PACLITAXEL; UNCLASSIFIED DRUG; WITHAFERIN A;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CYCLOADDITION; CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MICHAEL ADDITION; REACTION OPTIMIZATION;

CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES; WITHANOLIDES;

EID: 79960452173     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.05.012     Document Type: Article

References (27)

1. A.H. Banday, B.P. Mir, I.H. Lone, K.A. Suri, and H.M.S. Kumar Studies on novel D-ring substituted steroidal pyrazolines as potential anticancer agents Steroids 75 2010 805 809
2. S. Amslinger The tunable functionality of α,β-unsaturated carbonyl compounds enables their differential application in biological systems Chem Med Chem 5 2010 351 356
3. P. Talalay, M.J.D. Long, and H.J. Prochaska Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis Proc Natl Acad Sci USA 85 1988 8261 8265
4. S.L. McGovern, E. Caselli, N. Grigorieff, and B.K. Shoichet A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening J Med Chem 45 2002 1712 1722 (Pubitemid 34293537)
5. A.O. Aptula, and D.W. Roberts Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity Chem Res Toxicol 19 2006 1097 1105 (Pubitemid 44384841)
6. A. Petronelli, G. Pannitteri, and U. Testa Triterpenoids as new promising anticancer drugs Anti-cancer Drug 20 2009 880 892
7. B. Shohat, S. Gitter, A. Abraham, and D. Lavie Anti-tumor activity of withaferin A (NSC-101088) Cancer Chemother Rep 51 1967 271 276
8. S.M. Kupchan, W.K. Anderson, P. Bollinger, R.W. Doskotch, R.M. Smith, and J.A. Renauld Tumor inhibitors. XXXIX. Active principles of Acnistus arborescens. Isolation and structural and spectral studies of withaferin A and withacnistin J Org Chem 34 1969 3858 3866
9. R.D. Budhiraja, P. Krishan, and S. Sudhir Biological activity of withanolides J Sci Ind Res 59 2000 904 911
10. M. Furmanowa, D. Gajdzis-Kuls, J. Ruszkowska, Z. Czarnocki, G. Obidoska, and A. Sadowska In vitro propagation of Withania somnifera with immunosuppressive activity Planta Med 67 2001 146 149 (Pubitemid 32234678)
11. A. Grover, A. Shandilya, V.S. Bisaria, and D. Sundar Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes BMC Genomics 11 2010 S15 25
12. N. Sen, B. Banerjee, B.B. Das, A. Ganguly, T. Sen, and S. Pramanik Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex Cell Death Differ 14 2007 358 367 (Pubitemid 46092238)
13. P. Bargagna-Mohan, A. Hamza, Y. Kim, Y.K. Ho, N. Mor-Vaknin, and N. Wendschlag The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin Chem Biol 14 2007 623 634 (Pubitemid 46920982)
14. R.R. Falsey, M.T. Marron, G.M. Gunaherath, N. Shirahatti, D. Mahadevan, and A.A. Gunatilaka Actin microfilament aggregation induced by withaferin A is mediated by annexin II Nat Chem Biol 2 2006 33 38
15. M.M. Mirjalili, E. Moyano, M. Bonfill, R.M. Cusido, and J. Palazon Steroidal lactones from Withania somnifera, an ancient plant for novel Medicine Molecules 14 2009 2373 2393
16. D. Lavie, E. Glotter, and Y. Shvo Constituents of Withania somnifera Dun. Part IV: the structure of withaferin-A J Am Chem Soc 30 1965 7517 7531
17. B. Jayaprakasam, Y. Zhang, N.P. Seeram, and M.G. Nair Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves Life Sci 74 2003 125 132 (Pubitemid 37324225)
18. L. Misra, P. Lal, N.D. Chaurasia, R.S. Sangwan, S. Sinha, and R. Tuli Selective reactivity of 2-mercaptoethanol with 5β,6β-epoxide in steroids from Withania somnifera Seroids 73 2008 245 251 (Pubitemid 351181432)
19. R.P. Machin, A.S. Veleiro, V.E. Nicotra, J.C. Oberti, and J.M. Padron Antiproliferative activity of Withanolides against human breast cancer cell lines J Nat Prod 73 2010 966 968
20. Y. Xu, M.T. Marron, E. Seddon, S.T. McLauughlin, D.T. Ray, and L. Whitesell 2,3-Dihydrowithaferin A-3b-O-sulphate, a new potential prodrug of withaferin A from aeroponically grown Withania somnifera Bioorg Med Chem 17 2009 2210 2214
21. K. Kour, A. Pandey, K.A. Suri, N.K. Satti, K.K. Gupta, and S. Bani Restoration of stress-induced altered T cell function and corresponding cytokines patterns by Withanolide A Int Immunopharmacol 9 2009 1137 1144
22. F. Malik, A. Kumar, S. Bhushan, S. Khan, A. Bhatia, and S.A. Krishan Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine Apoptosis 12 2007 2115 2133 (Pubitemid 47498235)
23. Sangwan RS, Chaurasiya ND, Misra LN, Lal P, Uniyal GC, Sangwan NS, et al. Process for isolation of Withaferin-A from plant materials and products there form. Patent No.: US 7,108,870 B2; 2006.
24. 2) as a new, highly efficient and reusable heterogeneous catalyst for thia-Michael addition to α,β-unsaturated carbonyl compounds Tetrahedron Lett 49 2008 4272 4275
25. S.K. Yousuf, S.C. Taneja, and D. Mukherjee Multicomponent cascade transformation of d-glucal to furan-appended triazole glycoconjugates J Org Chem 75 2010 3097 3100
26. CAUTION: The reaction of TMSN3 with methanol no doubt releases HN3, which is a potential explosive. HN3 is soluble in organic solvents. Hence, all operations should be conducted behind a safety shield in order to avoid the explosion hazard from HN3 generated in this reaction and in the workup procedure.
27. W. Voigt Sulforhodamine B assay chemosensitivity Methods Mol Med 110 2005 39 48